Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity

AIM: The aim of this trial was to investigate the mechanism of action for body weight loss with semaglutide. MATERIALS AND METHODS: This randomised, double‐blind, placebo‐controlled, two‐period crossover trial investigated the effects of 12 weeks of treatment with once‐weekly subcutaneous semaglutid...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Blundell, John, Finlayson, Graham, Axelsen, Mads, Flint, Anne, Gibbons, Catherine, Kvist, Trine, Hjerpsted, Julie B.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573908/
https://ncbi.nlm.nih.gov/pubmed/28266779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12932
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars